3 London Mempool companies backed by Sofinnova Partners
Rank =128 of 430 on the investor leaderboard. A source says it led a round in 2 of them.
See them on the mapCounts only deals named in a source we fetched
- Health2
- AI1
Portfolio on the map (3)
London gene therapy company targeting kidney podocytes to treat diseases such as IgA nephropathy.
Health · Kidney Gene Therapy · Fastest growingLed a roundsource: purespringtx.com- Latent Labs$50M
Generative AI lab designing new proteins and antibodies, founded by AlphaFold co-developer Simon Kohl.
AI · Generative Protein Design · Fastest growingLed a roundsource: tech.eu King's College London spinout developing Lateral CAR-T cell therapies for solid tumours, now in a Phase I/IIa trial.
Health · CAR-T Therapy · Up and comingsource: leucid.com
We list Sofinnova Partners on a company only when a page we fetched names it as an investor. Its real London portfolio is likely bigger. Know a deal we missed? Suggest a fix with a source. How we count